Vaccine News and Research

Latest Vaccine News and Research

People with depression more likely to believe vaccine-related misinformation

People who feel depressed are more likely to believe vaccine-related misinformation, according to a new study coauthored by a Rutgers researcher during a time when depression rates are higher due to the COVID-19 pandemic.

22 Jan 2022

Vaccines alone are ineffective against the widely circulating Omicron variant

Millions of people around the world have received two shots of Sinovac, a Chinese-manufactured inactive vaccine that is used in 48 countries to help reduce transmission rates of COVID-19.

21 Jan 2022

New COVID-19 vaccine promises vaccine equity because it has no patents

Corbevax, a new vaccine against COVID-19, may have better success as a candidate for vaccine equity because it carries no patents, relies on long-established recombinant technology for manufacture and has the support of the US and Indian governments, its makers and health experts say.

21 Jan 2022

Study suggests SARS-CoV-2 Omicron variant spike mediated immune escape and tropism shift

A new study showed that the SARS-CoV-2 Omicron spike binds to its receptor with enhanced affinity and yet evades vaccine-elicited neutralizing antibodies and that a booster mRNA vaccine broadened the neutralization of Omicron.

21 Jan 2022

Call for pharmaceutical companies to release COVID-19 vaccine data

Scientists are beginning to grow worried about the seeming reluctance of these companies to release the raw data from the clinical trials.

21 Jan 2022

Nano-bubbles containing ACE2 protein can block infection from broad strains of SARS-CoV-2

Scientists at Northwestern Medicine and The University of Texas MD Anderson Cancer Center have identified natural nano-bubbles containing the ACE2 protein (evACE2) in the blood of COVID-19 patients and discovered these nano-sized particles can block infection from broad strains of SARS-CoV-2 virus in preclinical studies.

21 Jan 2022

New production method developed to freeze-dry COVID-19 vaccines

UMass Lowell scientists are developing a production method to freeze-dry COVID-19 vaccines activated by messenger-RNA so they can be transported and stored at room temperature.

21 Jan 2022

PAXLOVID shown to be highly effective against all SARS-CoV-2 variants

A recent study, currently available on bioRxiv* preprint server, shows that a novel protease inhibitor known as nirmatrelvir has potent activity against Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also other variants evaluated in this paper – which supports its potential role in reducing the disease burden from coronavirus disease 2019 (COVID-19).

21 Jan 2022

COVID-19 vaccination does not impair fertility, suggests BU study

New findings by Boston University School of Public Health investigators indicate that COVID-19 vaccination does not impair fertility - but males who become infected by the coronavirus may experience short-term reduced fertility.

21 Jan 2022

Laser-driven needle-free injection is more effective and safer than previous technologies

Fear of needles is, for part of the population, the main reason for not having a Covid-19 vaccine. That fear is of all times, clearly demonstrated by the fact that needleless techniques have been developed for over 150 years.

20 Jan 2022

Research shows benefits of hybrid immunity to SARS-CoV-2

Researchers examine the effects of previous SARS-CoV-2 infections on the immunity offered by SARS-CoV-2 vaccination.

20 Jan 2022

Cancer patients receiving treatment may mount inadequate immune response to COVID-19 vaccination

A study by researchers at Mayo Clinic Cancer Center has found that patients with cancer who receive chemotherapy - and some targeted therapies, such as CDK4/6 inhibitors and therapies targeted at B cells - may mount an inadequate immune response to COVID-19 vaccination.

20 Jan 2022

SARS-CoV-2 breakthrough infections elicit potent neutralizing antibody responses

A recent study looked at the strength, durability and breadth of neutralizing antibody responses generated by breakthrough infections in individuals vaccinated against SARS-CoV2.

20 Jan 2022

COVID-19 vaccination does not appear to impair fertility, study says

COVID-19 vaccination does not affect the chances of conceiving a child, according to a study of more than 2,000 couples that was funded by the National Institutes of Health.

20 Jan 2022

New report reveals the alarming global impact of Group B streptococcus

A new report from the World Health Organization (WHO) and the London School of Hygiene & Tropical Medicine (LSHTM) reveals the alarming global impact of Group B streptococcus (GBS) – a common bacterium that can be transmitted in the womb, during birth, or in the early weeks of life – leading to around 150,000 deaths of babies each year, more than half a million preterm births and significant long-term disability.

20 Jan 2022

Biden administration’s rapid-test rollout doesn’t easily reach those who need it most

In the past week, the Biden administration launched two programs that aim to get rapid covid tests into the hands of every American. But the design of both efforts disadvantages people who already face the greatest barriers to testing.

20 Jan 2022

Scientists explore the possibility of Omicron ending the COVID-19 pandemic

A new analysis parses out what scientists currently know about the Delta variant and predicts what the end of the COVID-19 pandemic might look like.

20 Jan 2022

New cryo-EM method may be able to shortcut a big step in modern vaccine development

Scientists at Scripps Research have devised a method that may be able to shortcut one of the big steps in modern vaccine development.

20 Jan 2022

Determining COVID-19 vaccine effectiveness among health care workers in Wales

A new study revealed an overall high vaccine uptake and significant vaccine effectiveness of BNT162b2 against COVID-19, among healthcare workers in Wales.

20 Jan 2022

Natural extracellular vesicles containing ACE2 protein could fight new SARS-CoV-2 variants

Scientists at The University of Texas MD Anderson Cancer Center and Northwestern Medicine have identified natural extracellular vesicles containing the ACE2 protein (evACE2) in the blood of COVID-19 patients that can block infection from broad strains of SARS-CoV-2 virus in preclinical studies. The study was published today in Nature Communications.

20 Jan 2022

Vaccine News and Research

Latest Vaccine News and Research

People with depression more likely to believe vaccine-related misinformation

Vaccines alone are ineffective against the widely circulating Omicron variant

New COVID-19 vaccine promises vaccine equity because it has no patents

Study suggests SARS-CoV-2 Omicron variant spike mediated immune escape and tropism shift

Call for pharmaceutical companies to release COVID-19 vaccine data

Nano-bubbles containing ACE2 protein can block infection from broad strains of SARS-CoV-2

New production method developed to freeze-dry COVID-19 vaccines

PAXLOVID shown to be highly effective against all SARS-CoV-2 variants

COVID-19 vaccination does not impair fertility, suggests BU study

Laser-driven needle-free injection is more effective and safer than previous technologies

Research shows benefits of hybrid immunity to SARS-CoV-2

Cancer patients receiving treatment may mount inadequate immune response to COVID-19 vaccination

SARS-CoV-2 breakthrough infections elicit potent neutralizing antibody responses

COVID-19 vaccination does not appear to impair fertility, study says

New report reveals the alarming global impact of Group B streptococcus

Biden administration’s rapid-test rollout doesn’t easily reach those who need it most

Scientists explore the possibility of Omicron ending the COVID-19 pandemic

New cryo-EM method may be able to shortcut a big step in modern vaccine development

Determining COVID-19 vaccine effectiveness among health care workers in Wales

Natural extracellular vesicles containing ACE2 protein could fight new SARS-CoV-2 variants

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in